The IO Rechallenge panel session at Uromigos Live featured Thomas Powles, MD; Brian Rini, MD; Tian Zhang, MD; Toni Choueiri, MD; and David McDermott, MD.
Click the image below to access the slide PDFs.
IO Rechallenge: Live Session From The Uromigos Live & Unplugged 2024
By Thomas Powles, MBBS, MRCP, MD, Brian Rini, MD, FASCO, Tian Zhang, MD, Toni Choueiri, MD, David F. McDermott, MD - Last Updated: October 2, 2024Related Posts
Drs. Beckermann and Braun discuss the latter's Nature publication on a personalized neoantigen vaccine for RCC.
Patients with mRCC on Medicare have better survival rates compared with patients on Medicaid or with no insurance.
A recent proof-of-concept study has further evaluated the efficacy of PSMA-guided MDT for oligometastatic RCC.
The panel concludes with future directions in RCC, including HIF inhibitors and biomarker-guided adjuvant strategies.
The panel considers how managing real-world patients on novel therapies like belzutifan presents a multitude of challenges.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.